# 432 Spectrum of BRCA1, BRCA2, PALB2, ATM and TP53 pathogenic variants in breast and ovarian cancer patients of tatar and bashkir ethnic origin
…, E Bakayeva, A Sultanbayev, R Faiskhanova… - 2023 - ijgc.bmj.com
Introduction/Background Tatarstan and Bashkortostan are large republics located nearby
Volga river. Although they joined Russia about five hundred years ago, they managed to …
Volga river. Although they joined Russia about five hundred years ago, they managed to …
The search for new candidate genes involved in ovarian cancer pathogenesis by exome sequencing
DS Prokofyeva, ET Mingajeva, NV Bogdanova… - Russian Journal of …, 2016 - Springer
Ovarian cancer is one of the most insidious of tumors among gynecological cancers in the
world. BRCA1 and BRCA2 mutations are associated with high risk of ovarian cancer; …
world. BRCA1 and BRCA2 mutations are associated with high risk of ovarian cancer; …
1171 Debulking surgery for treatment advanced-stage ovarian cancer with HIPEC compared with debulking surgery without HIPEC, short-term outcomes
N Tarasov, R Faiskhanova, A Fatikhova, R Bainazarov… - 2021 - ijgc.bmj.com
Introduction/Background* The gold standart of advanced-stage ovarian cancer treatment is
debulking surgery and systematic chemotherapy. However, alternative ways of drug delivery …
debulking surgery and systematic chemotherapy. However, alternative ways of drug delivery …
Clinical case of gastric cancer in patient with hereditary BRCA-associated ovarian cancer
RR Faiskhanova, DD Sakaeva - Medical alphabet, 2021 - med-alphabet.com
The detection of tumor-like formations in the area of the uterine appendages during
dispensary observation in patients who have undergone treatment for malignant neoplasms …
dispensary observation in patients who have undergone treatment for malignant neoplasms …
[CITATION][C] The hereditary ovarian cancer: role of candidate genes in disease pathogenesis
RR Faiskhanova, DS Prokofieva… - Medical …, 2019 - medgen-journal.ru
[CITATION][C] Features of the clinical course and molecular genetic characteristics of hereditary ovarian cancer [dissertation]
RR Faiskhanova - 2021 - Moscow